Rockefeller Capital Management L.P. Grows Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Rockefeller Capital Management L.P. lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 18.8% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 160,441 shares of the company's stock after acquiring an additional 25,393 shares during the period. Rockefeller Capital Management L.P. owned 1.06% of U.S. Physical Therapy worth $13,578,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of USPH. Canada Pension Plan Investment Board bought a new stake in U.S. Physical Therapy in the 2nd quarter valued at about $28,000. Innealta Capital LLC purchased a new stake in U.S. Physical Therapy in the 2nd quarter valued at about $30,000. Quest Partners LLC increased its position in shares of U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company's stock valued at $32,000 after acquiring an additional 337 shares during the last quarter. Quarry LP increased its position in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after purchasing an additional 478 shares during the last quarter. Finally, Ridgewood Investments LLC bought a new stake in U.S. Physical Therapy in the second quarter worth about $51,000.

U.S. Physical Therapy Price Performance

NYSE:USPH traded down $0.38 during mid-day trading on Tuesday, hitting $98.99. 95,174 shares of the stock traded hands, compared to its average volume of 93,445. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.49 billion, a PE ratio of 105.49, a price-to-earnings-growth ratio of 4.49 and a beta of 1.46. The business's 50-day moving average price is $86.93 and its 200 day moving average price is $90.29.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be issued a $0.44 dividend. The ex-dividend date of this dividend is Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.78%. U.S. Physical Therapy's payout ratio is currently 187.23%.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,724 shares of the business's stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares in the company, valued at approximately $684,236.74. The trade was a 19.52 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the transaction, the director now owns 1,112 shares in the company, valued at approximately $107,552.64. The trade was a 51.31 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,896 shares of company stock valued at $656,940. 1.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

USPH has been the subject of several research reports. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st. JPMorgan Chase & Co. boosted their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the company an "overweight" rating in a research note on Tuesday. Barrington Research reiterated an "outperform" rating and set a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, Bank of America reissued a "neutral" rating and issued a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a research report on Monday, October 7th.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.